These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 11898721)

  • 21. FPIN's clinical inquiries. Best alternatives to statins for treating hyperlipidemia.
    Bouknight P; Mackler L; Heffington M
    Am Fam Physician; 2007 Oct; 76(7):1027-9. PubMed ID: 17956075
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute nateglinide administration in subjects with type 2 diabetes: effects on postprandial metabolism, coagulation, and fibrinolysis.
    Tentolouris N; Boutati E; Karambakalis N; Perrea D; Tselepis AD; Tsoukala C; Kyriaki D; Lourida E; Anastasopoulou I; Karafoullidou A; Raptis SA; Katsilambros N
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):6-12. PubMed ID: 15871845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins and omega-3 fatty acids in the treatment of dyslipidemia and coronary heart disease.
    Nordøy A
    Minerva Med; 2002 Oct; 93(5):357-63. PubMed ID: 12410168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative evaluation of hypolipidemic effects of omega-3 polyunsaturated acids and lipostabil].
    Pogozheva AV; Bobkova SN; Samsonov MA; Vasil'ev AV
    Vopr Pitan; 1996; (4):31-3. PubMed ID: 8984798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of diet including omega-3 polyunsaturated fatty acids on the status of T-cell immunity in patients with ischemic heart disease and hyperproteinemia].
    Sorokovoĭ KV; Pogozheva AV; Sergeeva KV
    Vopr Pitan; 1997; (5):6-8. PubMed ID: 9460842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of omega-3 fatty acids on cardiovascular risk factors in patients with type 2 diabetes mellitus and hypertriglyceridemia: an open study.
    De Luis DA; Conde R; Aller R; Izaola O; González Sagrado M; Perez Castrillón JL; Dueñas A; Romero E
    Eur Rev Med Pharmacol Sci; 2009; 13(1):51-5. PubMed ID: 19364085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Eiconol effects on hemocoagulation in coronary heart disease patients].
    Dzhanashiia PK; Panchenko VM; Nazlukhanian SO; Chernova GI; Liutova LV; Semenov VA; Korneenkov VK; Perekrestova EI; Nurmukhamedov SA; Andreenko GI
    Klin Med (Mosk); 1997; 75(10):55-7. PubMed ID: 9490343
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effects of n-3 polyunsaturated fatty acids on hemorheology and coagulation in atherosclerotic rats].
    Yang YB; Li P; Liu ML
    Zhonghua Yi Xue Za Zhi; 2010 Jul; 90(28):2004-7. PubMed ID: 20979870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of omega-3 polyunsaturated fatty acids of vegetable and animal origin on clinical and metabolic indicators and the intensity of lipid peroxidation in patients with ischemic heart disease and impaired carbohydrate tolerance].
    Gapparova KM; Pogozheva AV; Kulakova SN; Tutel'ian VA
    Vopr Pitan; 2000; 69(1-2):46-9. PubMed ID: 10943007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid-lowering drugs and essential omega-6 and omega-3 fatty acids in patients with coronary heart disease.
    de Lorgeril M; Salen P; Guiraud A; Zeghichi S; Boucher F; de Leiris J
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):36-41. PubMed ID: 15871849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The role of omega-3 fatty acids from fish in prevention of cardiovascular diseases].
    Reiner E; Tedeschi-Reiner E; Stajminger G
    Lijec Vjesn; 2007; 129(10-11):350-5. PubMed ID: 18257336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertriglyceridemia: management of atherogenic dyslipidemia.
    Bersot T; Haffner S; Harris WS; Kellick KA; Morris CM
    J Fam Pract; 2006 Jul; 55(7):S1-8. PubMed ID: 16822443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of the administration of n-3 polyunsaturated fatty acids on circulating levels of microparticles in patients with a previous myocardial infarction.
    Del Turco S; Basta G; Lazzerini G; Evangelista M; Rainaldi G; Tanganelli P; Christensen JH; Schmidt EB; De Caterina R
    Haematologica; 2008 Jun; 93(6):892-9. PubMed ID: 18469350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do polyunsaturated fatty acids behave like an endogenous "polypill"?
    Das UN
    Med Hypotheses; 2008; 70(2):430-4. PubMed ID: 17624683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The essential fatty acids omega-6 and omega-3: from their discovery to their use in therapy].
    Caramia G
    Minerva Pediatr; 2008 Apr; 60(2):219-33. PubMed ID: 18449139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of fluvastatin on prothrombotic and fibrinolytic factors in type 2 diabetes mellitus.
    Tan KC; Janus ED; Lam KS
    Am J Cardiol; 1999 Oct; 84(8):934-7, A7. PubMed ID: 10532516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The influence of the dietary polyunsaturated fatty acids on the phagocyte's functional activity in rats].
    Trushina EN; Mustafina OK; Kulakova SN
    Vopr Pitan; 2003; 72(4):9-11. PubMed ID: 12968296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of low-dose polyunsaturated fatty acids supplementation on the inflammatory response of healthy adults.
    Schubert R; Kitz R; Beermann C; Rose MA; Baer PC; Zielen S; Boehles H
    Nutrition; 2007 Oct; 23(10):724-30. PubMed ID: 17664057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of low-dose omega-3 fatty acid substitution in type-2 diabetes mellitus with special reference to oxidative stress--a prospective preliminary study.
    Jain S; Gaiha M; Bhattacharjee J; Anuradha S
    J Assoc Physicians India; 2002 Aug; 50():1028-33. PubMed ID: 12421024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omega-3 polyunsaturated fatty acids (Omacor) for hypertriglyceridemia.
    Med Lett Drugs Ther; 2005 Nov; 47(1221):91. PubMed ID: 16267495
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.